The invention features a method for treating an immunoinflammatory
administering a compound of formula (I), e.g., ibudilast or KC-764, alone
or in combination with a corticosteroid, tetra-substituted
pyrimidopyrimidine, or other compound. The invention also features
pharmaceutical compositions including the combination above for the
treatment or prevention of an immunoinflammatory disorder.